fasting test
Showing 1 - 25 of >10,000
Fasting Trial in Basel (mixed meal test)
Recruiting
- Fasting
- mixed meal test
-
Basel, SwitzerlandUniversity Hospital Basel
Nov 10, 2023
Gestational Diabetes, Diagnoses Disease, Pregnancy in Diabetic Trial in Stanford (Fasting before gestational diabetes screen,
Completed
- Gestational Diabetes
- +3 more
- Fasting before gestational diabetes screen
- Per oral intake of food and drink
-
Stanford, CaliforniaStanford University
Oct 26, 2022
Pharmacokinetics, Safety Trial (Test Preparation-Reference preparation, Reference preparation-Test Preparation)
Not yet recruiting
- Pharmacokinetics
- Safety
- Test Preparation-Reference preparation
- Reference preparation-Test Preparation
- (no location specified)
May 16, 2022
Upper Respiratory Tract Infection, Lower Respiratory Infection, Skin Infection Trial in Beijing (test product (T) azithromycin
Completed
- Upper Respiratory Tract Infection
- +4 more
- test product (T) azithromycin capsule and reference product (R) azithromycin capsule "Sumamed®"
-
Beijing, Beijing, ChinaPeking University People's Hospital
Nov 20, 2023
Bioequivalence Trial in Moscow (Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg
Recruiting
- Bioequivalence
- Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet
-
Moscow, Russian FederationLigand Research LLC
Jul 7, 2023
Healthy Trial (Test (T) Bilastine, Reference (R) Bilastine)
Not yet recruiting
- Healthy
- Test (T) Bilastine
- Reference (R) Bilastine
- (no location specified)
Oct 19, 2023
Bioequivalence Trial in Yaroslavl (Clopidogrel film-coated tablet 75 mg, Plavix® film-coated tablet 75 mg)
Recruiting
- Bioequivalence
- Clopidogrel film-coated tablet 75 mg
- Plavix® film-coated tablet 75 mg
-
Yaroslavl, Yaroslavl Region, Russian FederationState Autonomous Healthcare Facility of the Yaroslavl Region "Cl
Jun 28, 2023
Hypertension and Dyslipidemia Trial in Seoul (CKD-386(4) F1, CKD-386(4) F2, D013, D326, D337)
Completed
- Hypertension and Dyslipidemia
- CKD-386(4) F1
- +2 more
-
Seoul, Korea, Republic ofH+ Yangji Hospita
Jan 10, 2023
Pharmacokinetics, Safety Trial in Qingdao (Reference preparation-Reference preparation-Test Preparation, Reference
Enrolling by invitation
- Pharmacokinetics
- Safety
- Reference preparation-Reference preparation-Test Preparation
- +2 more
-
Qingdao, Shandong, ChinaPhase I clinical research center
Jul 28, 2022
Healthy Individuals Trial in Karachi (Test Drug, Reference Drug)
Recruiting
- Healthy Individuals
- Test Drug
- Reference Drug
-
Karachi, Sindh, PakistanMuhammad Raza Shah
Dec 18, 2022
Bioequivalence Trial in Moscow (Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg, Tritace® Plus tablet 10 mg/25 mg)
Not yet recruiting
- Bioequivalence
- Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg
- Tritace® Plus tablet 10 mg/25 mg
-
Moscow, Russian FederationSeparate medical division "Comed" (Ligand Research LLC)
Jan 5, 2023
Bioequivalence Trial in Yaroslavl (Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg)
Recruiting
- Bioequivalence
- Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg
-
Yaroslavl, Russian FederationState Budgetary Healthcare Institution of the Yaroslavl Region "
Nov 30, 2022
Bioequivalence Trial in Moscow (Ramipril tablet 10 mg / Tritace® tablet 10 mg)
Recruiting
- Bioequivalence
- Ramipril tablet 10 mg / Tritace® tablet 10 mg
-
Moscow, Russian FederationLigand Research LLC
Jun 24, 2022
Bioequivalence Trial in Yaroslavl (Lisinopril tablet 20 mg, Zestril® tablet 20 mg)
Completed
- Bioequivalence
- Lisinopril tablet 20 mg
- Zestril® tablet 20 mg
-
Yaroslavl, Yaroslavl Region, Russian FederationPrivate healthcare institution "Clinical Hospital "RZD-Medicine"
Jul 4, 2022
Bioequivalence Trial in Karachi (Lamotrigine tablet)
Completed
- Bioequivalence
- Lamotrigine tablet
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research
Sep 5, 2022
Bioequivalence Trial in Saint Petersburg (Aceclofenac film-coated tablet 100 mg, Airtal® film-coated tablet 100 mg)
Active, not recruiting
- Bioequivalence
- Aceclofenac film-coated tablet 100 mg
- Airtal® film-coated tablet 100 mg
-
Saint Petersburg, Russian FederationX7 Clinical Research
Jun 29, 2022
Gastric Assessment of Pediatric Patients Undergoing Surgery
Not yet recruiting
- Fasting
- +3 more
- Gastric Ultrasound Baseline Scans
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 5, 2023
Bioequivalence Trial in Lesnoy (Aviga, capsules 50 mg / Sutent®, capsules 50 mg, Sutent®, capsules 50 mg / Aviga, capsules 50
Not yet recruiting
- Bioequivalence
- Aviga, capsules 50 mg / Sutent®, capsules 50 mg
- Sutent®, capsules 50 mg / Aviga, capsules 50 mg
-
Lesnoy, Minsk Region, BelarusNational Anti-Doping Laboratory
Jan 20, 2022
Bioequivalence Trial in Cairo (Test product (T) 40 mg Hard Gelatin Capsules, Reference product (R) 40 mg Hard Gelatin Capsules)
Completed
- Bioequivalence
- Test product (T) 40 mg Hard Gelatin Capsules
- Reference product (R) 40 mg Hard Gelatin Capsules
-
Cairo, EgyptFuture Research Center (FRC)
Feb 10, 2022
Bioequivalence, Schizophrenia Trial in Qingdao (Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and
Recruiting
- Bioequivalence
- Schizophrenia
- Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University Phase I Clinical R
Sep 27, 2023
Diabetes Trial (Vildagliptin 50 MG)
Completed
- Diabetes Mellitus
- Vildagliptin 50 MG
- (no location specified)
Apr 14, 2022
Bioequivalence Trial in Cairo (Test product (T) 25 mg Film Coated Tablets, Reference product (R) 25 mg Film Coated Tablets)
Completed
- Bioequivalence
- Test product (T) 25 mg Film Coated Tablets
- Reference product (R) 25 mg Film Coated Tablets
-
Cairo, EgyptFuture Research Center (FRC)
Feb 10, 2022
Healthy Trial in Qingdao (reference eldecalcitol soft capsule, test eldecalcitol soft capsule)
Completed
- Healthy
- reference eldecalcitol soft capsule
- test eldecalcitol soft capsule
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Jun 1, 2022
Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 500/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 29, 2023